Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bellicum Pharmaceuticals Stock (OTC: BLCM) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.2.407K / 28.449K | Mkt Cap3.531M |
Day Range- - - | 52 Wk Range0.225 - 1.500 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-02-16 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 5.00 |
2020-10-30 | Wells Fargo | Jim Birchenough | Downgrades | OverweightEqual-Weight | Announces | - | 4.50 |
2020-03-13 | Raymond James | Reni Benjamin | Maintains | Outperform | Lowers | 40.00 | 17.00 |
2018-08-09 | Citigroup | - | Maintains | BuyBuy | Lowers | 22.00 | 19.00 |
You can purchase shares of Bellicum Pharmaceuticals (OTCPK: BLCM) through any online brokerage.
There are no as such competitors for Bellicum Pharmaceuticals.
The latest price target for Bellicum Pharmaceuticals (OTCPK: BLCM) was reported by Ladenburg Thalmann on Wednesday, February 16, 2022. The analyst firm set a price target for 5.00 expecting BLCM to rise to within 12 months (a possible 1244.72% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellicum Pharmaceuticals (OTCPK: BLCM) is $0.371825 last updated September 21, 2023 at 4:53 PM UTC.
There is no dividend information for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Bellicum Pharmaceuticals.
Bellicum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.